Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/1AD stock hub

ASX/1AD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/1ADis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.7M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/1AD

In the news

Latest news · ASX/1AD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROEn/a

P25 -118.7P50 -49.4P75 -1.2

ROIC-340.5

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/1AD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

AUD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	1
Employees Change	-8%
Employees Change Percent	-88.89
Enterprise value	AUD 11.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000001AD2
Last refreshed	2026-05-10
Market cap	AUD 12.7M
Price	AUD 0.01
Price currency	AUD
Rev Per Employee	608,074x
Sector	Healthcare
Sic	2836
Symbol	asx/1AD
Website	https://www.adalta.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-34.22%
EV Earnings	-2.56x
EV/Sales	18.36x
P/B ratio	-58.3x
P/S ratio	20.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	63.92%
Gross Profit	AUD 388,706
Gross Profit Growth	-15.04%
Gross Profit Growth Q	-24.95%
Gross Profit Growth3 Y	-36.36%
Gross Profit Growth5 Y	-33.52%
Net Income	AUD -4.4M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-717.51%
Profit Per Employee	AUD -4.4M
ROA	-122.7
Roa5y	-47.19
ROCE	1,880.2
Roe5y	-249.9
ROIC	-340.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.02%
Cagr3y	-36.27%
Cagr5y	-46.34%
EPS Growth Quarters	7
EPS Growth Years	6
Revenue Growth	-37.51x
Revenue Growth Q	-18.38x
Revenue Growth Years	0x
Revenue Growth3 Y	-29.53x
Revenue Growth5 Y	-29.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.29
Assets	AUD 1.8M
Cash	AUD 1.6M
Current Assets	AUD 1.8M
Current Liabilities	AUD 2.1M
Equity	AUD -218,656
Interest Coverage	-14.67
Liabilities	AUD 2.1M
Long Term Assets	AUD 0
Long Term Liabilities	AUD 0
Net Cash	AUD 1.6M
Net Cash By Market Cap	AUD 12.42
Tangible Book Value	AUD -218,656
Tangible Book Value Per Share	AUD -0
WACC	5.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.89
Net Working Capital	AUD -1.8M
Quick ratio	0.89
Working Capital	AUD -218,656
Working Capital Turnover	AUD 1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-97.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25%
200-day SMA	0
3Y total return	-74.12%
50-day SMA	0
50-day SMA vs 200-day SMA	50over200
5Y total return	-95.55%
All Time High	0.4
All Time High Change	-98.75%
All Time High Date	2018-03-06
All Time Low	0
All Time Low Change	150%
All Time Low Date	2025-05-21
ATR	0
Beta	0.2
Beta1y	0.33
Beta2y	0.27
Ch YTD	66.67
High	0.01
High52	0.01
High52 Date	2026-01-08
High52ch	-37.5%
Low	0.01
Low52	0
Low52 Date	2025-10-17
Low52ch	150%
Ma50ch	19.05%
Price vs 200-day SMA	38.89%
RSI	61.94
RSI Monthly	33.45
RSI Weekly	53.83
Sharpe ratio	0.78x
Sortino ratio	1.35
Total Return	-97.37%
Tr YTD	66.67
Tr1m	25%
Tr1w	11.11%
Tr3m	11.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -4.1M
Operating margin	-676.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,668,898,258%
Net Borrowing	-405,132
Shares Insiders	32.4%
Shares Institutions	5.03%
Shares Out	2,549,669,043
Shares Qo Q	124.82%
Shares Yo Y	97.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,622,392.65x
Bv Per Share	-0
Ch1m	25
Ch1w	11.11
Ch1y	25
Ch3m	11.11
Ch3y	-78.26
Ch5y	-96.3
Ch6m	66.67
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	-50,632
Dollar Volume	63,044
Earnings Date	2026-05-20
EBIT	AUD -4.1M
EBITDA	AUD -4.2M
EPS	AUD -0
F Score	2
Financing CF	2,290,837
Fiscal Year End	June
Founded	2,006
Investing CF	109,615
Is Primary Listing	1
Last Earnings Date	2026-02-22
Last Report Date	2025-12-31
Ma150	0
Ma150ch	28.21%
Ma20	0
Ma20ch	19.05%
Net CF	-43,642
Next Earnings Date	2026-05-20
Open	0.01
Price Date	2026-05-08
Relative Volume	3.71x
Revenue	608,074x
SBC By Revenue	11.97x
Share Based Comp	72,757
Tr6m	66.67%
Volume	12,608,791
Z Score	-46.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/1AD pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/1AD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/1AD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.0%

Share of float held by funds and institutions

Insider ownership

+32.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+97.4%

Negative means the company is buying back shares.

Technical

ASX/1AD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.9

Neutral momentum band

Price vs 200-day MA

+38.9%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/1AD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/1AD stock rating?

asx/1AD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/1AD analysis?

The full report lives at /stocks/asx/1AD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/1AD?

The latest report frames asx/1AD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/1AD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.